COA-Based Endpoints Addressed in FDA Patient-Focused Drug Development Guidance
May 2, 2023
The FDA has published the fourth and final guidance in its patient-focused drug development series, offering stakeholders recommendations for incorporating clinical outcome assessments (COA) into trial endpoints.